Huang Zhong
huangzhong@ips.ac.cn
Chinese, English
Shanghai
University of Chinese Academy of Sciences
Medical School
  • 1991-09 to 1997-06 PhD: China Agricultural University
  • 1987-09 to 1991-06 Bachelor's Degree: China Agricultural University
  • 2009-01 to Present - Shanghai Pasteur Institute, Chinese Academy of Sciences - Researcher, Group Leader
  • 2005-09 to 2008-12 - Arizona State University - Assistant Research Professor
  • 2002-09 to 2005-09 - Arizona State University - Senior Research Associate
  • 1998-02 to 2002-09 - Boyce Thompson Institute, Cornell University - Postdoctoral Researcher
  • Shanghai Outstanding Technical Leader (2015)
  • Chinese Academy of Sciences **** Selected (2010)
Development of vaccines and antiviral strategies for important viral diseases (Hand, Foot, and Mouth Disease, Hepatitis C, Norovirus infection, etc.)
Novel genetic engineering vaccines and therapeutic monoclonal antibodies
  • High-yield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice, Zhang C, Ku Z, Liu Q, Wang X, Chen T, Ye X, Li D, Jin X, Huang Z., 2015
  • Towards broadly protective polyvalent vaccines against hand, foot and mouth disease, Liu Q, Tong X, Huang Z., 2015
  • Phylogenetic analysis of the major causative agents of hand, foot and mouth disease in Suzhou City, Jiangsu Province, China, in 2012-2013, Zhang C, Zhu R, Yang Y, Chi Y, Yin J, Tang X, Yu L, Zhang C, Huang Z, Zhou D., 2015
  • Fighting Ebola with ZMapp: spotlight on plant-made antibody, Zhang Y, Li D, Huang Z., 2014
  • A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice, Ku Z, Liu Q, Ye X, Cai Y, Wang X, Shi J, Li D, Jin X, An W, Huang Z., 2014
  • A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses, Cai Y, Ku Z, Liu Q, Leng Q, Huang Z., 2014
  • A murine model of coxsackievirus A16 infection for anti-viral evaluation, Liu Q, Shi J, Huang X, Liu F, Cai Y, Lan K, Huang Z., 2014
  • The molecule of DC-SIGN captures enterovirus 71 and confers dendritic cell-mediated viral trans-infection, Ren X, Ma L, Liu Q, Li C, Huang Z, Wu L, Xiong S, Wang J, Wang H., 2014
  • Chimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms, Ye X, Ku Z, Liu Q, Wang X, Shi J, Zhang Y, Kong L, Cong Y, Huang Z., 2014
  • Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16, Shi J, Huang X, Liu Q, Huang Z., 2013
  • Active immunization with a coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection, Cai Y, Liu Q, Huang X, Li D, Ku Z, Zhang Y, Huang Z., 2013
  • Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps, Ku Z, Ye X, Huang X, Cai Y, Liu Q, Li Y, Su Z, Huang Z., 2013
  • Characterization of enterovirus 71 capsids using subunit protein-specific polyclonal antibodies, Liu Q, Huang X, Ku Z, Wang T, Liu F, Cai Y, Li D, Leng Q, Huang Z., 2013
  • A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge, Liu Q, Yan K, Feng Y, Huang X, Ku Z, Cai Y, Liu F, Shi J, Huang Z., 2012
  • Development of murine monoclonal antibodies with potent neutralization effects on enterovirus 71, Ku Z, Shi J, Liu Q, Huang Z., 2012
  • Construction and characterization of an infectious clone of coxsackievirus A16, Liu F, Liu Q, Cai Y, Leng Q, Huang Z., 2011
  • Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins, Liu Q, Ku Z, Cai Y, Sun B, Leng Q, Huang Z., 2011
  • Single-Particle Tracking of Hepatitis B Virus-like Vesicle Entry into Cells, Hao X, Shang X, Wu J, Shan Y, Cai M, Jiang J, Huang Z, Tang Z, Wang H., 2011
  • Expression of VP0 protein of enterovirus 71 in E.coli and generation of corresponding polyclonal antibodies, Feng Y, Liu Q, Ku Z, Wen J, Shan H, Huang Z., 2011
Vaccine Antiviral Hand Foot And Mouth Disease Hepatitis C Norovirus Genetic Engineering Monoclonal Antibodies Virus-Like Particles Immunology Therapeutics

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.